As expected, overall survival (p = 0.0088) and disease-free survival (p = 0.0575) were higher in the patients bearing a tumor with shallow deletion of both BECN1 and BRCA1 compared to those bearing a tumor with a diploid CNV of the two tumor suppressor genes (Figure 5A,B). Here, BRCA1 is linked to neoplasm.